Target intelligence / Profile preview

T lymphocyte (T cell) (T cell)

Target
T cell
Molecular classification
Other
01

Overview

T lymphocytes, or T cells, are a fundamental lineage of white blood cells that play a central role in the adaptive immune response (StatPearls: T-Cell Lymphocytes, 2023). Originating from hematopoietic stem cells in the bone marrow and maturing in the thymus, these cells are distinguished by the presence of a T-cell receptor (TCR) on their surface (Wikipedia: T cell, 2024). Polyclonal T lymphocytes refer to a heterogeneous population of T cells with a diverse repertoire of TCRs, enabling the recognition of a wide array of antigens (Nature Reviews Immunology: T cell functions, 2021). In therapeutic contexts, this population is often targeted for depletion using polyclonal antibodies like anti-thymocyte globulin (ATG) to prevent or treat organ transplant rejection and graft-versus-host disease (StatPearls: Antithymocyte Globulin, 2023). Additionally, the expansion of polyclonal T cells is a critical step in adoptive cell therapies, such as tumor-infiltrating lymphocyte (TIL) therapy, where the cells are harvested, activated, and re-infused to combat malignancies (NCI: TIL Therapy, 2023). Pharmacological modulation of T cells, whether through immunosuppression in autoimmune diseases or activation in cancer immunotherapy, remains a primary strategy in modern medicine (PubMed: T cell modulation, 2022).

Other names
T cellsT-lymphocytesThymus-derived lymphocytesPolyclonal T cells
02

Mechanism of action

T-cell depletion via complement-dependent cytotoxicity and opsonization; inhibition of T-cell receptor signaling and IL-2 mediated proliferation (StatPearls: Antithymocyte Globulin, 2023; NIH: Immunosuppressive Agents, 2022).

03

Biological functions

Immune responseCell-mediated immunityCytokine productionImmunological memoryAntigen recognition
04

Disease associations

Graft-versus-host diseaseOrgan transplant rejectionAplastic anemiaAutoimmune diseaseCancer
05

Safety considerations

Cytokine release syndrome (StatPearls, 2023)Serum sickness (NIH, 2022)Anaphylaxis (StatPearls, 2023)Increased risk of opportunistic infections (StatPearls, 2023)Lymphopenia (StatPearls, 2023)
06

Interacting drugs

Anti-thymocyte globulin (StatPearls, 2023)

7 more in the full profile.

07

Biomarkers

CD3 (Mayo Clinic, 2023)CD4 (Mayo Clinic, 2023)CD8 (Mayo Clinic, 2023)Absolute lymphocyte count (StatPearls, 2023)T-cell receptor diversity (Nature, 2021)

Beyond the preview

Go deeper on T lymphocyte (T cell) (T cell).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T lymphocyte (T cell) (T cell).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call